From method development to qualification to validation and transfer, it is a continuous yet inter-dependent process from early research to development to QC and release. Depending on which stage of product development you are in, your method may or may not need to be robust, qualified or validated. The objective is to prove that methods selected are fit for their intended purpose.
With an expanded portfolio of newer formats and non-mAbs in the pipelines, knowledge, experience and advanced techniques are critical to establish efficient, accurate and fit-for-purpose analytical methods that can be later qualified, validated and transferred to release testing, thereby improving efficiency and reducing cost, time and resources.
Sheraton Inner Harbor
300 South Charles St.
Baltimore, MD 21201
Discounted Room Rate: $179 s/d
Discounted Room Rate Cut-off Date: February 13, 2018
TOP REASONS TO STAY AT THE SHERATON INNER HARBOR:
• Located in Baltimore's historic and scenic Inner Harbor
• Complimentary wireless internet in your guestroom
• Just steps from the hotel you'll find waterfront with ample shops and restaurants
• National Aquarium, museums, ballparks and other attractions just minutes away
Join us in Baltimore, Maryland, on March 12-16, 2018 for CHI's 9th Annual Biotherapeutics Analytical Summit.
The Biotherapeutics Analytical Summit, with its hallmark brand of topics on Method Development, Qualification & Validation, Advances in Characterization Methods & Approaches and Comparability & Biosimilarity, and its signature mix of regulators, industry and academia speakers, has come to be known as THE Analytical Summit where attendees can hear and learn about real-life case studies, innovative concepts and practical approaches that can help scientists advance their molecules from discovery to development and commercialization.